P1.111. The Presence of Signet Ring Cells Predicts Aggressive Chemotherapy Resistance in Esophageal Adenocarcinoma
Clicks: 4
ID: 325695
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.9
/100
4 views
3 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #86 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Topic Esophageal Cancer: Molecular Biology/Pathology Background Esophageal adenocarcinoma (EAC) remains a rapidly rising and poorly controlled malignancy worldwide, despite radical surgery and multimodal therapy. Signet ring cells (SRC) are classically known to signal a more aggressive cancer and are associated with poorer oncologic outcomes, compared to non-signet ring cell adenocarcinoma (NSRC). Little is known, however, regarding the course of this disease in the setting of perioperative chemotherapy. We sought to elucidate the effect of SRC in resectable EAC patients receiving perioperative chemotherapy. Methods A single-centre retrospective chart review was performed of all EAC patients treated with neoadjuvant systemic therapy, followed by esophagectomy, from 2012-2023. Patients receiving preoperative radiation and patients with metastatic disease were excluded. Clinical variables, including tumour histology, clinical staging, treatment regimens, tumour regression grade (TRG), recurrence, and survival, were extracted. Group variables were compared by t-test, chi-squared test, or Fisher’s exact test. A multivariate regression model was used to assess the independent effect of signet ring cells on chemoresistance. Survival curves were estimated by the Kaplan-Meier method. Results 450 patients were included in this study, 51 (11%) of whom had a component of SRC identified on histology. Between the SRC and NSRC cohorts, there were no differences in age, comorbidities, clinical stage, and chemotherapy regimens. SRC tumours had poorer differentiation (86% G3 vs. 40%, p<0.01) and exhibited more chemoresistance (57% TRG3 vs. 33%, p<0.01). Subgroup analysis of poorly differentiated (G3) tumours showed congruent chemoresistive effect (62% TRG3 vs. 34%, p=0.02). On multivariate analysis, the presence of SRC remained an independent predictor of chemoresistance (OR 2.36, 95% CI 1.25–4.59, p<0.01). The SRC cohort showed poorer 5-year OS (36% vs. 47%, p<0.01) and 5-year DFS (23% vs. 39%, p<0.01). Conclusion In the setting of perioperative chemotherapy, the presence of SRC is associated with increased chemoresistance on univariate and multivariate analyses, as well as poorer survival. Our findings suggest increased chemoresistance as a causal mechanism of poorer oncologic outcomes in esophageal SRC adenocarcinomas. Future work is required to understand the biology of this disease and identify potential therapeutic targets.
| Reference Key |
openalex_W7203914983
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Andrew Meng, Luis Santos Castro, D. Hamidi, Adolfo De Motta Molina, Mehrnoush Dehghani, J. Cools-Lartigue, Jonathan Spicer, Mathieu Rousseau, Sara Najmeh, Jamil Asselah, Sara Soldera, Pierre-Olivier Fiset, Greta Evaristo, Carmen Mueller, Lorenzo Ferri |
| Journal | diseases of the esophagus : official journal of the international society for diseases of the esophagus |
| Year | 2026 |
| DOI |
10.1093/dote/doag077.259
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.